Liz Crowe: "Is it Moral to Feel Moral Distress?"
Critical Care Medicine
Upon completion of this activity, you should be able to:
info_outline
Professor Andrew Udy: "Brain Monitoring in Traumatic Brain Injury"
Critical Care Medicine
Upon completion of this activity, you should be able to:
info_outline
Professor Michael O'Leary: "Organ Donation"
Critical Care Medicine
After completing this lecture you will be able to:
info_outline
Professor Greg Hare: "Patient Blood Management and Treatment of Anemia in Critical Care"
Critical Care Medicine
Coming soon
info_outline
Ramesh Venkataraman: "Renal Replacement Therapy for AKI"
Critical Care Medicine
After watching the lecture you should be able to:
info_outline
Professor Kathryn Maitland: "Management of Gastroenteritis in Resource Limited Settings"
Critical Care Medicine
At the end of this lecture, you should be able to:
info_outline
Federico Angriman: "Non-Invasive Oxygenation Strategies"
Critical Care Medicine
On completion of this lecture, you will be able to:
info_outline
Tim Baker: "Essential Emergency & Critical Care"
Critical Care Medicine
Upon completion of this activity, you should be able to:
info_outline
Professor Charles Sprung: "Foregoing Life-Sustaining Treatment in the ICU"
Critical Care Medicine
Upon completion of this activity, you should be able to:
info_outline
Paul Young: "Potential Solutions to the Problems of Clinical Trial Science"
Critical Care Medicine
On completion of this activity you should be able to:
info_outlineIn the last five years, the introduction of cellular therapies has revolutionized the management of haematological cancers. The success of this approach has encouraged others to seek novel means to treat a variety of critical illness syndromes. In this talk, we will review the current state of cell-based immune modulation for ARDS and sepsis. We will address the classification and biology of investigational cell therapies, alongside a discussion of the challenges associated with scaling them for widespread clinical use.